Kurt Xiaodong Wang has been the President of C-RAD China since Jan of 2018, and the Sales Director of China since Sept of 2015. Kurt has more than 17 years of working experience. He had previously worked for Cardinal Health China as a Senior Oncology Solution manager, Elekta China as a product manager, and Sales manager of CMS ( TPS company, Acquired by Elekta).  Kurt holds a master’s degree in Bio-Medical Engineering from Tsinghua University, Bachelor’s degree in Material Science and Technology from Xi’an Jiaotong University.

Holdings in C-RAD: 40 000 B-shares, 32 163 warrants.